247 related articles for article (PubMed ID: 8798974)
21. Immunomodulatory effects of the HIV-1 gp120 protein on antigen presenting cells: implications for AIDS pathogenesis.
Conti L; Fantuzzi L; Del Cornò M; Belardelli F; Gessani S
Immunobiology; 2004; 209(1-2):99-115. PubMed ID: 15481145
[TBL] [Abstract][Full Text] [Related]
22. Biological properties of anti-CD4 autoantibodies purified from HIV-infected patients.
Chams V; Idziorek T; Klatzmann D
AIDS; 1991 May; 5(5):565-9. PubMed ID: 1677809
[TBL] [Abstract][Full Text] [Related]
23. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Xiao X; Kinter A; Broder CC; Dimitrov DS
Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
[TBL] [Abstract][Full Text] [Related]
24. The cell surface marker phenotype of macrophages from HIV-1-infected subjects reflects an IL-10-Enriched and IFN-gamma-deprived donor environment.
Orlikowsky T; Wang ZQ; Dudhane A; Horowitz H; Conti B; Hoffmann M
J Interferon Cytokine Res; 1996 Nov; 16(11):957-62. PubMed ID: 8938573
[TBL] [Abstract][Full Text] [Related]
25. Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation.
Mittler RS; Hoffmann MK
Science; 1989 Sep; 245(4924):1380-2. PubMed ID: 2571187
[TBL] [Abstract][Full Text] [Related]
26. Human immunodeficiency virus type 1 glycoprotein 120-specific T lymphocytes provide intermolecular help for anti-CD4 autoantibody production in exposed uninfected subjects.
Furci L; Beretta A; Siccardi A; Lazzarin A; Confetti C; Magnani Z; Scarpellini P; Lopalco L; Burastero SE
AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1461-9. PubMed ID: 9390745
[TBL] [Abstract][Full Text] [Related]
27. AIDS pathogenesis: HIV envelope and its interaction with cell proteins.
Habeshaw JA; Dalgleish AG; Bountiff L; Newell AL; Wilks D; Walker LC; Manca F
Immunol Today; 1990 Nov; 11(11):418-25. PubMed ID: 2078296
[TBL] [Abstract][Full Text] [Related]
28. Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120.
Hioe CE; Jones GJ; Rees AD; Ratto-Kim S; Birx D; Münz C; Gorny MK; Tuen M; Zolla-Pazner S
AIDS Res Hum Retroviruses; 2000 Jun; 16(9):893-905. PubMed ID: 10875615
[TBL] [Abstract][Full Text] [Related]
29. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
Capobianchi MR
J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
[TBL] [Abstract][Full Text] [Related]
30. Recognition of HIV glycoprotein gp120 by T cells. Role of monocyte CD4 in the presentation of gp120.
Siliciano RF; Knall C; Lawton T; Berman P; Gregory T; Reinherz EL
J Immunol; 1989 Mar; 142(5):1506-11. PubMed ID: 2537355
[TBL] [Abstract][Full Text] [Related]
31. Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1).
Pal R; Nair BC; Hoke GM; Sarngadharan MG; Edidin M
J Cell Physiol; 1991 May; 147(2):326-32. PubMed ID: 2040664
[TBL] [Abstract][Full Text] [Related]
32. Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule.
Cottrez F; Manca F; Dalgleish AG; Arenzana-Seisdedos F; Capron A; Groux H
J Clin Invest; 1997 Jan; 99(2):257-66. PubMed ID: 9005994
[TBL] [Abstract][Full Text] [Related]
33. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.
Weinhold KJ; Lyerly HK; Stanley SD; Austin AA; Matthews TJ; Bolognesi DP
J Immunol; 1989 May; 142(9):3091-7. PubMed ID: 2468713
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune T-cell response to the CD4 molecule in HIV-infected patients.
Caporossi AP; Bruno G; Salemi S; Mastroianni C; Falciano M; Salotti A; Bergami N; Santilio I; Nisini R; Barnaba V
Viral Immunol; 1998; 11(1):9-17. PubMed ID: 9586693
[TBL] [Abstract][Full Text] [Related]
36. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Celada F; Düzgüneş N
J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
[TBL] [Abstract][Full Text] [Related]
37. AIDS and immune dysfunction. Alternative etiologic mechanisms.
del Guercio P
Contrib Microbiol Immunol; 1989; 11():289-304. PubMed ID: 2573482
[No Abstract] [Full Text] [Related]
38. HIV-1 gp120 modulates the immunological function and expression of accessory and co-stimulatory molecules of monocyte-derived dendritic cells.
Williams MA; Trout R; Spector SA
J Hematother Stem Cell Res; 2002 Oct; 11(5):829-47. PubMed ID: 12427289
[TBL] [Abstract][Full Text] [Related]
39. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
[TBL] [Abstract][Full Text] [Related]
40. A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells.
Chamow SM; Zhang D; Tan XY; Mhatre SM; Marsters SA; Peers DH; Byrn RA; Ashkenazi A; Junghans RP
J Hematother; 1995 Oct; 4(5):439-46. PubMed ID: 8581382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
